To evaluate DNA methylation changes associated with IDH-mutant glioma progression, we analyzed the number of DMPs between paired tumors of individual patients (“temporal intratumor DMPs”) and between tumor groups (i.e. unpaired primary vs. recurrent tumors). This evidence concerns the gene IDH2 and glioma.